Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors

Margit Fuchs, Peter Hutzler, Ingrid Brunner, Jürgen Schlegel, Jörg Mages, Ute Reuning, Sandra Hapke, Justus Duyster, Setsuo Hirohashi, Takuya Genda, Michiie Sakamoto, Florian Überall, Heinz Höfler, Karl Friedrich Becker, Birgit Luber

Research output: Contribution to journalArticle

19 Citations (Scopus)

Fingerprint Dive into the research topics of 'Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences